Once-Promising Heart Failure Drug Fails in Trial
It’s ‘the end of the story’ for rolofylline against this tough-to-treat condition, researcher saysContinue Reading
It’s ‘the end of the story’ for rolofylline against this tough-to-treat condition, researcher saysContinue Reading
Appears to lengthen survival time, but study is small, researchers sayContinue Reading
Infants exposed to influenza vaccine had less illness, increased antibodies, finds studyContinue Reading
Researchers found docs prescribing them with some frequencyContinue Reading
Parents urged to get children vaccinated, as annual season startsContinue Reading
Dutch researchers report that dexamethasone, along with antibiotics, increases survival ratesContinue Reading
But trial of drug was stopped after some patients got worse, researchers sayContinue Reading
2-year survival rate was 66 percent, compared to 46 percent for conventional therapyContinue Reading
Drug also reduced contagious period and fever duration during H1N1 pandemic, researchers sayContinue Reading
Those with non-small cell cancers found to have mutation that responds to drug treatmentContinue Reading
Finding could influence the use of statins to prevent heart disease, researchers suggestContinue Reading
Wider use would be cost-effective prevention method, researchers sayContinue Reading
Blood markers for the disease rose from 1 in every 501 individuals in 1974 to 1 in 219 by 1989Continue Reading
Older drug-eluting model prevents more major cardiac events than a newer version, researchers findContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.